Zachary Q. Beck, Ph.D. - Publications

Affiliations: 
2001 Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Area:
Biochemistry

9/14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Ding Y, Seufert WH, Beck ZQ, Sherman DH. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity. Journal of the American Chemical Society. 130: 5492-8. PMID 18366166 DOI: 10.1021/Ja710520Q  0.356
2007 Seufert W, Beck ZQ, Sherman DH. Enzymatic release and macrolactonization of cryptophycins from a safety-catch solid support. Angewandte Chemie (International Ed. in English). 46: 9298-300. PMID 17979172 DOI: 10.1002/Anie.200703665  0.305
2006 Beck ZQ, Sherman DH. Development of an internally quenched fluorogenic substrate for kinetic analysis of thioesterases. Analytical Biochemistry. 349: 309-11. PMID 16360105 DOI: 10.1016/J.Ab.2005.10.038  0.316
2005 Beck ZQ, Aldrich CC, Magarvey NA, Georg GI, Sherman DH. Chemoenzymatic synthesis of cryptophycin/arenastatin natural products. Biochemistry. 44: 13457-66. PMID 16216069 DOI: 10.1021/Bi051140U  0.35
2003 Lin YC, Beck Z, Morris GM, Olson AJ, Elder JH. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases. Journal of Virology. 77: 6589-600. PMID 12767979 DOI: 10.1128/Jvi.77.12.6589-6600.2003  0.607
2002 Beck ZQ, Morris GM, Elder JH. Defining HIV-1 protease substrate selectivity. Current Drug Targets. Infectious Disorders. 2: 37-50. PMID 12462152 DOI: 10.2174/1568005024605837  0.583
2001 Beck ZQ, Lin YC, Elder JH. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases. Journal of Virology. 75: 9458-69. PMID 11533208 DOI: 10.1128/Jvi.75.19.9458-9469.2001  0.631
2000 Beck ZQ, Hervio L, Dawson PE, Elder JH, Madison EL. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. Virology. 274: 391-401. PMID 10964781 DOI: 10.1006/Viro.2000.0420  0.626
2000 Lin YC, Beck Z, Lee T, Le VD, Morris GM, Olson AJ, Wong CH, Elder JH. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease Journal of Virology. 74: 4710-4720. PMID 10775609 DOI: 10.1128/Jvi.74.10.4710-4720.2000  0.634
Low-probability matches (unlikely to be authored by this person)
2011 Primak YA, Du M, Miller MC, Wells DH, Nielsen AT, Weyler W, Beck ZQ. Characterization of a feedback-resistant mevalonate kinase from the archaeon Methanosarcina mazei. Applied and Environmental Microbiology. 77: 7772-8. PMID 21908638 DOI: 10.1128/Aem.05761-11  0.288
2006 Magarvey NA, Beck ZQ, Golakoti T, Ding Y, Huber U, Hemscheidt TK, Abelson D, Moore RE, Sherman DH. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts. Acs Chemical Biology. 1: 766-79. PMID 17240975 DOI: 10.1021/Cb6004307  0.227
2007 Beck ZQ, Burr DA, Sherman DH. Characterization of the beta-methylaspartate-alpha-decarboxylase (CrpG) from the cryptophycin biosynthetic pathway. Chembiochem : a European Journal of Chemical Biology. 8: 1373-5. PMID 17600793 DOI: 10.1002/Cbic.200700162  0.194
2006 Magarvey NA, Beck ZQ, Simon MD, Feldman ME, Rosivatz E, Pokharel S. Introduction to Our Authors Acs Chemical Biology. 1: 728-729. DOI: 10.1021/Cb600482X  0.159
2015 Rabin BM, Heroux NA, Shukitt-Hale B, Carrihill-Knoll KL, Beck Z, Baxter C. Lack of reliability in the disruption of cognitive performance following exposure to protons. Radiation and Environmental Biophysics. 54: 285-95. PMID 25935209 DOI: 10.1007/s00411-015-0597-2  0.053
Hide low-probability matches.